Featured Research

from universities, journals, and other organizations

Voice-saver: Light therapy for early-stage laryngeal cancer

Date:
January 29, 2011
Source:
Henry Ford Health System
Summary:
A new study finds light, or photodynamic therapy, can help preserve the voice in patients with early stage laryngeal cancer. Photodynamic therapy works by destroying deadly cancer cells without harming surrounding healthy tissue by using a powerful laser and a nontoxic, light-activated drug. It also has fewer side-effects than radiation and surgery.

Light, or photodynamic, therapy can help preserve the voice and vocal cord function for patients with early stage laryngeal (voice box) cancer, according to a study from Henry Ford Hospital in Detroit.

"Photodynamic therapy is an effective treatment for early laryngeal squamous cell carcinomas, offering patients a less invasive option with fewer side effects than other therapies, while preserving the voice," says study co-author Vanessa G. Schweitzer, FACS, M.D., a senior staff physician in the Department of Otolaryngology-Head & Neck Surgery at Henry Ford.

The study will be presented Jan. 29 at the Triological Society's Combined Section Meeting in Scottsdale, Ariz.

Each year in the United States, more than 10,000 people are diagnosed with laryngeal cancer. Those who smoke and drink alcohol are at a greater risk, according to the National Cancer Institute. Laryngeal cancer is most commonly treated with radiation therapy alone or in combination with surgery or chemotherapy.

But photodynamic therapy offers some patients another option.

"It is a good alternative to radiation and surgery for early staged lesions. It can preserve function and allow us to reserve use of radiation therapy and surgery -- both known to have more functional impairment on vocal cord function -- should the cancer recur following photodynamic therapy," says study lead author Melissa L. Somers, M.D., with the Department of Otolaryngology-Head and Neck Surgery at Henry Ford.

Having already performed more than 200 procedures -- more than any other hospital in Michigan -- Henry Ford physicians are center stage in the application and research for this procedure.

Photodynamic therapy works by destroying deadly cancer cells without harming surrounding healthy tissue. It uses a powerful laser and a nontoxic, light-activated drug called PHOTOFRIN. The laser activates the drug, causing a reaction in the cancer cells and destroying them.

Since photodynamic therapy does not damage the underlying tissue, it not only allows for multiple treatments but also for it to be given prior to or following other therapies, and when radiation therapy fails.

However, there is not a consensus in research literature as to which treatment -- surgery, radiation therapy or photodynamic therapy -- produces the best outcome for voice preservation.

The current Henry Ford study focuses on 10 patients with early stage squamous cell tumors of the larynx treated with photodynamic therapy. The study assessed how well the vocal cords moved following photodynamic therapy.

Both before and after photodynamic therapy, patients underwent videostroboscopy exams, a state-of-the-art technique that provides a magnified, slow-motion view of the vocal cords in use. The technique uses a small, angled telescope inserted through the mouth or nose to measure vocal cord vibrations while patients repeat words or sounds.

Results were analyzed by a speech language pathologist and laryngologist specializing in voice disorders for vocal cord movement and vibration.

During the first five weeks following treatment, researchers noted a significant worsening in the non-vibrating portion of the affected vocal cords, which is expected, says Dr. Somers.

Ten weeks following treatment, there was a noticeable improvement.

"In our study, patients undergoing PDT demonstrated initial significant impairment in the vocal cord vibratory parameters of mucosal wave, non-vibrating vocal cold and amplitude of vibration as well as appearance of vocal cold edge for both the tumor and non-tumor side," says Dr. Somers. "Most notably, over the course of a few weeks and months, there were consistent trends toward normal vocal cord vibration."

Patients do experience minor side effects from treatment such as photosensitivity, making them more sensitive to light and susceptible to severe sunburns. This lasts for about four weeks following the procedure. Patients also may experience temporary hoarseness.

Dr. Somers hopes future studies are aimed at a prospective comparison of photodynamic therapy to surgery and radiation and subsequent voice production results.

Funding: Henry Ford Hospital

Along with Dr. Schweitzer and Dr. Somers, Henry Ford study co-authors are Glendon M. Gardner, M.D.; Alice K. Silbergleit, Ph.D., CCC-SLP; and Ed Peterson, M.D.


Story Source:

The above story is based on materials provided by Henry Ford Health System. Note: Materials may be edited for content and length.


Cite This Page:

Henry Ford Health System. "Voice-saver: Light therapy for early-stage laryngeal cancer." ScienceDaily. ScienceDaily, 29 January 2011. <www.sciencedaily.com/releases/2011/01/110128104240.htm>.
Henry Ford Health System. (2011, January 29). Voice-saver: Light therapy for early-stage laryngeal cancer. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2011/01/110128104240.htm
Henry Ford Health System. "Voice-saver: Light therapy for early-stage laryngeal cancer." ScienceDaily. www.sciencedaily.com/releases/2011/01/110128104240.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins